- On 25 September, Hifas da Terra Received The Nutraberum 2024 Award for Best Nutraceutical Company IN SPAIN DURING THE 10TH EDITION OF THE FARMAFORUM CONGRESS, HIGHLIGING ITS LEADERSHIP IN THE FOOD SUPPLY INDUSTRY.
- Hifas da Terra is focused on disruptive innovation from a One Health Perspective, Seeking to Meet The Needs of the Population with Safe Solutions Supported by its scientific evidence.
- Since 2021, Hifas da Terra has experienced exponential Growth in International Sales, Exceeding 500%, Solidifying its International Expansion.
View this post on Instagram
Hifas da Terra Has Been Awarded The Nutraberum 2024 Award for Best Nutraceutical Company, collect its commitment to innovation and the revealing of high-qualylity nutraceutical products. Nutraforum is part of a spanish pharmaceutical industry event: pharmaforum.
The Award Was presented to Claudia Fernández, Hifas da Terra’s Innovation Hub Manager, By Lois Fraiz Ares, director of nutraforum, During The Tenth-Anniversary Celebration of the Farmaforum Congress. The Cereony Attracted Over 7,200 Industry Professionals, with participation from Key Figures Including Eugenio Pérez de Lema Carmona, General Director of Farmaforum; Eduardo Sanz Sánchez, director of the Farmaforum Congress; and Marcos Muiños Docampo, Commercial Director of Farmaforum.
Growth of More than 500%
Hifas da Terra Continues to Solidify Its Leadership in the Research and Commercialisation of Functional Mushroom-Based Nutracaceuticals, Achieving Over 500% Growth In International Sales outside The European Union Since 2021.
Fernández Emphasised The Importance of Evaluating Profitability and Feasibility From The Project's Inception, particularly when navigating regulations and potential Costs Associated with Novel Foods.
Safe Solutions Supported by Scientific Evidence
"The Most Critical Phases of the Projects are Undoubtedly The Initial One PROJECT IS Economically Viable and Can Reach The Market Within The Establish Timeframe, "
International Growth
The Increase in Sales Abroad Partly Explains The Growth and Expansion of Hifas da Terra. 10% of STIs Total Sales NOW Come from Countries Outsis The EU. FERNÁNDEZ EXPLAEDED THAT GROWTH INSEE MARKETS HAS BEEN EXPONENTIAL AND HIGHIGTED THE IMPORTANCE OF ADAPTING TO LOCAL REGULATIONS, TARIFF BARRIERS AND THE CHALLENGES ARISING FROM GEOPOLITICAL TENSIONS.
This Award Not only reapffirms Hifas da Terra’s Position in the Nutraceutical Sector Sector Underscores ITS Commitment to Innovation and Sustainable Development In Advancing Health Through Science and Biotechnology.
Hifas da Terra
Hifas da Terra is a Biotech Based on Research and Innovation, With Degree of Specialisation in the Development of Nutraceuticals from Functional Mushrooms, With Processions and Products Protected by patent or KEPT Under Industrial Secrecy.
Health Professionals from Different Countries Trust in The Formulas Of Hifas da Terra, Forming to multidisciplinary prescription network of more than 20,000 experts with whom it collolable through iTS Subsidiaries and Distributors in Europe, The United States, The Middle East and New Emerging Countries.
Hifas da Terra Has A Team Led By Dr. Catalina Fernández de Ana Portela, in Addition to Groups of National and International Scientific Advisors. The Company Develop Formulas Harnessing The Bioactive Properties of Functional Mushrooms, From Research to Production and Purification